MED — MED SA Income Statement
0.000.00%
Last trade - 00:00- €11.32m
- €16.47m
- €4.54m
Annual income statement for MED SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 4.11 | 4.54 |
| Cost of Revenue | ||
| Gross Profit | 2.77 | 3.58 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 3.98 | 4.05 |
| Operating Profit | 0.132 | 0.487 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -0.026 | 0.371 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 0.016 | 0.263 |
| Minority Interest | ||
| Net Income Before Extraordinary Items | ||
| Net Income | -0.14 | 0.084 |
| Adjustments to Net Income | ||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -0.14 | 0.084 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.012 | 0.002 |